天新药业: 重大经营与投资决策管理制度

Core Viewpoint - The article outlines the major operational and investment decision management system of Jiangxi Tianxin Pharmaceutical Co., Ltd, emphasizing the need for a scientific, standardized, and transparent decision-making process to protect the interests of the company and its shareholders [3][4]. Summary by Sections General Principles - The system aims to establish a comprehensive decision-making mechanism for significant operational and investment decisions, ensuring compliance with relevant laws and regulations [3]. - The principles of decision-making include scientific democratization, procedural standardization, and effectiveness in industrial investment [3]. Decision-Making Authority and Procedures - The company implements a layered decision-making system involving the shareholders' meeting, board of directors, and general manager, with subsidiaries having limited decision-making authority [3][4]. - Major operational and investment decisions require approval based on specific thresholds related to total asset value, transaction amounts, and profit contributions [3][4][5]. - For decisions exceeding certain financial thresholds, approval from the shareholders' meeting is required, while others may be approved by the board of directors or delegated to the chairman [8][9]. Decision-Making Process - Prior to investment decisions, the responsible business department must conduct market research and provide feasibility analysis for review by the general manager's office [10]. - Factors considered in decision-making include compliance with laws, alignment with company strategy, economic viability, and necessary resources for implementation [11]. Execution and Supervision - The execution of approved investment projects is managed by the responsible business department, with financial departments ensuring proper funding allocation [14]. - Internal audits are conducted to monitor financial performance of investment projects, and public bidding processes are mandated for fixed asset investments [14][15]. Additional Provisions - The system will be effective upon approval by the shareholders' meeting and will be interpreted by the board of directors [11][16].